Paediatric pharmacy - Drug therapy

Hospital Pharmacist

Volumn 10, Issue 2, 2003, Pages 49-57

  Conroy, Sharon ^a  

^a UNIVERSITY OF NOTTINGHAM   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT;

ADVERSE DRUG REACTION; DECISION MAKING; DOSE CALCULATION; DRUG ABSORPTION; DRUG COST; DRUG DISTRIBUTION; DRUG DOSAGE FORM; DRUG EFFECT; DRUG EXCRETION; DRUG METABOLISM; DRUG MONITORING; DRUG SAFETY; ERROR; HUMAN; INFECTION; INTENSIVE CARE; LICENSING; NEWBORN INTENSIVE CARE; PARENTERAL NUTRITION; PATIENT; PEDIATRICS; PHARMACIST; PHARMACY; REVIEW;

EID: 0037319738     PISSN: 13527967     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (28)

1. The European Agency for the Evaluation of Medicinal Products. ICH Topic E11 Note for guidance on clinical investigation of medicinal products in the paediatric population (CPMP/ICH/2711/99). London: EMEA; 2000.
2. Morselli PL, Franco-Morselli R, Bossi L. Clinical pharmacokinetics in newborns and infants, age-related differences and therapeutic implications. Clin Pharmacokinet 1980;5:485-527.
3. Goutieres F, Aicardi J. Accidental percutaneous hexachlorophane intoxication in children. BMJ 1977;2:663-5.
4. Barrett DA, Rutter N. Transdermal delivery and the premature neonate. Crit Rev Ther Drug Carrier Syst 1994;11:1-30.
5. Walson PD. Paediatric clinical pharmacology and therapeutics. In: Speight TM, Holford NHG, editors. Avery's Drug Treatment. 4th ed. Auckland, New Zealand: Adis Press; 1997. pp127-71.
6. de Hoog M, Mouton JW, van den Anker JN. The use of aminoglycosides in newborn infants. Paediatr Perinat Drug Therapy 1998;2:48-56.
7. van den Anker JN, Hop WCJ, de Groot R, van der Heijden BJ, Broerse HM, Lindemans J et al. Effects of prenatal exposure to betamethasone and indometacin on the glomerular filtration rate in the preterm infant. Pediatr Res 1994;36:578-81.
8. Pharmacy Department. Royal Liverpool Children's Hospital (Alder Hey). Alder Hey Book of Children's doses. 6th ed. Liverpool; 1994.
9. Pharmacy Department. Guy's, St Thomas' and Lewisham Hospitals. Paediatric Formulary. 5th ed. London; 1999.
10. The Northern Neonatal Network. Neonatal Formulary. 3rd ed. London: BMJ Books; 2000.
11. The Royal College of Paediatrics and Child Health and the Neonatal and Paediatric Pharmacists Group. Medicines for children. RCPCH Publications Limited on behalf of the RCPCH and the Neonatal and Paediatric Pharmacists Group. London; 1999.
12. Conroy S, McIntyre J, Choonara I. Unlicensed and off-label drug use in neonates. Arch Dis Child Fetal Neonatal Ed 1999;80:F142-5.
13. Turner S, Gill A, Nunn T, Hewitt B, Choonara I. Use of off-label and unlicensed drugs in paediatric intensive care unit. Lancet 1996;347:549-50.
14. Conroy S, Choonara I, Impicciatore P, Mohn A, Arnell H, Rane A et al. Survey of unlicensed and off-label drug use in paediatric wards in European countries. BMJ 2000;320:79-82.
15. Conroy S, McIntyre J, Choonara I, Stephenson T. Drug trials in children: problems and the way forward. Br J Clin Pharmacol 2000;49:93-7.
16. Peden V, Choonara I, Gennery B, Done H. Recruiting children to a clinical trial. Paediatr Perinat Drug Therapy 2000;4:75-8.
17. European Commission. Better medicines for children. Consultation document. Brussels: The Commission; 2002.
18. Spielberg SP. Paediatric therapeutics in the US and internationally: an unparalleled opportunity. Paediatr Perinat Drug Therapy 2000;4:71-4.
19. Department of Health and Human Services. US Food and Drug Administration. The Paediatric Exclusivity Provision. Status Report to Congress. Rockville: Department of Health and Human Services, FDA; 2001.
20. Brion F, Nunn AJ, Rieutord A. Extemporaneous (magistral) preparation of oral medicines for children in European Hospitals. Acta Paediatrica 2003. In press.
21. Dyer C. GMC clears doctors on accidental morphine overdose. BMJ 1999;318:1167.
22. Soldin OP, Soldin SJ. Review: therapeutic drug monitoring in paediatrics. Ther Drug Monit 2002;24:1-8.
23. Koren G. Therapeutic drug monitoring principles in the neonate. Clin Chem 1997;43:222-7.
24. Gilman J. Therapeutic drug monitoring in the neonatal and paediatric age group: problems and clinical pharmacokinetic implications. Clin Pharmacokinetics 1990;19:1-10.
25. Weitzman M, Shiffman RN. Editorial: Information technology and the future of child health care. A revolution is occurring. Arch Pediatr Adolesc Med 2001;155:990-1.
26. Bates DW. Using information technology to reduce rates of medication errors in hospitals. BMJ 2000;320:788-91.
27. Kaushal R, Barker KN, Bates DW. How can information technology improve patient safety and reduce medication errors in children's health care? Arch Pediatr Adolesc Med 2001;155:1002-7.
28. Mullet CJ, Scott Evans R, Christenson JC, Michael Dean J. Development and impact of a computerized pediatric anti-infective decision support program. Pediatrics 2001;108:e75.